May 1, 2018Read More
ITS – Engineering Tomorrow's
Breakthrough Biologics Today
ITS is a technology company that empowers its partners to unlock the full, transformational potential of biologics to improve human health.
We are the pioneers of a ground-breaking, next generation protein engineering technology that represents a new paradigm for drug discovery.
With our technology, first in class drug discovery is now possible for ANY target, enabling our partners to target the undruggable.
Our HuTARG technology is a revolutionary platform for antibody and protein engineering that effectively exploits mammalian display at the scale of billions of unique variants and does not require cloning or transformation of large recombinant libraries, or liquid handling robotics.
The platform generates its diversity by using nature’s most powerful diversity generator – V(D)J recombination – to isolate and engineer at the scale of billions directly.
ITS has built momentum and sustained its success by collaborating and partnering with the world’s leading pharmaceutical companies to leverage our technology to tackle specific target classes and therapeutic indications that enable the creation of high quality, first in class biologics.